Table 1.
Demographic profile and baseline characteristics of amphetamine positive individuals who developed cardiovascular complications (n = 42).
| Parameter | Median (range) or n (%) |
|---|---|
| Age (y) | 39 (21–60) |
| Sex (male) | 42 (100) |
| Nationality (Saudi) | 40 (95%) |
| Body mass index (kg/m2) | 27 (18.5–40.8) |
| Heart rate (beats/min) | 87 (36–130) |
| >100 | 9 (21) |
| <60 | 3 (7) |
| Respiratory rate (breaths/min) | 20 (12–32) |
| Systolic blood pressure (mmHg) | 126 (70–160) |
| >140 | 7 (16.6) |
| <100 | 6 (14) |
| Diastolic blood pressure (mmHg) | 71 (41–114) |
| >90 | 3 (7) |
| <60 | 9 (21) |
| Oxygen saturation (%) | 98 (90–100) |
| Smoking: current/ex-smoker | 25 (60) |
| Nonsmoker | 9 (20) |
| Unknown | 8 (20) |
| Admit amphetamine-type stimulants use | 19 (45) |
| Multidrug use by urine test | 17 (41) |
| Type II diabetes mellitus | 11 (27.5) |